162 related articles for article (PubMed ID: 10200559)
1. JNK/SAPK activity contributes to TRAIL-induced apoptosis.
Herr I; Wilhelm D; Meyer E; Jeremias I; Angel P; Debatin KM
Cell Death Differ; 1999 Feb; 6(2):130-5. PubMed ID: 10200559
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
[TBL] [Abstract][Full Text] [Related]
3. JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha.
Herr I; Wilhelm D; Böhler T; Angel P; Debatin KM
Int J Cancer; 1999 Jan; 80(3):417-24. PubMed ID: 9935184
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions.
Cantarella G; Risuglia N; Lombardo G; Lempereur L; Nicoletti F; Memo M; Bernardini R
Cell Death Differ; 2004 May; 11(5):503-11. PubMed ID: 14739940
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
6. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM
Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599
[TBL] [Abstract][Full Text] [Related]
7. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
Mikami T; Koyama T; Koyama T; Imakiire A; Yamamoto K; Furuhata M; Toyota H; Mizuguchi J
Anticancer Res; 2006; 26(2A):1153-60. PubMed ID: 16619517
[TBL] [Abstract][Full Text] [Related]
8. JNK activation is not required for Fas-mediated apoptosis.
Low W; Smith A; Ashworth A; Collins M
Oncogene; 1999 Jun; 18(25):3737-41. PubMed ID: 10391681
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway.
Jurewicz A; Matysiak M; Andrzejak S; Selmaj K
Glia; 2006 Jan; 53(2):158-66. PubMed ID: 16206163
[TBL] [Abstract][Full Text] [Related]
10. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
12. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
13. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
Yu R; Mandlekar S; Ruben S; Ni J; Kong AN
Cancer Res; 2000 May; 60(9):2384-9. PubMed ID: 10811114
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
Nakshatri H; Rice SE; Bhat-Nakshatri P
Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
[TBL] [Abstract][Full Text] [Related]
16. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.
Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
Cancer Res; 1999 May; 59(10):2457-63. PubMed ID: 10344758
[TBL] [Abstract][Full Text] [Related]
17. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.
Yanase N; Hata K; Shimo K; Hayashida M; Evers BM; Mizuguchi J
Exp Cell Res; 2005 Oct; 310(1):10-21. PubMed ID: 16099454
[TBL] [Abstract][Full Text] [Related]
18. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
[TBL] [Abstract][Full Text] [Related]
19. Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line.
Sarker M; Ruiz-Ruiz C; López-Rivas A
Cell Death Differ; 2001 Feb; 8(2):172-81. PubMed ID: 11313719
[TBL] [Abstract][Full Text] [Related]
20. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
